LD-2 disclosure · 2nd Quarter - Report
F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES
Client
- Location
- District of Columbia · United States of America
Registrant
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
(HCR): S.4348 FDASLA Act of 2022/ H.R. 7667 Food and Drug Amendments of 2022, H.R. 4128/S. 2209 The Verifying Accurate Leading-edge IVCT Development Act, H.R. 6000 CURES Act. Issues related to public health emergency preparedness, including S. 3799 PREVENT Pandemics Act
Lobbyistsmr RUSSELL CONWELL RING · NANCY CARLTON · BRENNA MARIE LEAMER
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Health & Human Services, Dept of (HHS) · Natl Institutes of Health (NIH)
Medical/Disease Research/Clinical Labs
(MED): S.4348 FDASLA Act of 2022/ H.R. 7667 Food and Drug Amendments of 2022, H.R. 4128/S. 2209 The Verifying Accurate Leading-edge IVCT Development Act, H.R. 6000 CURES Act. Issues related to public health emergency preparedness, including S. 3799 PREVENT Pandemics Act
Lobbyistsmr RUSSELL CONWELL RING · NANCY CARLTON · BRENNA MARIE LEAMER
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Natl Institutes of Health (NIH)
Medicare/Medicaid
(MMM) Clinical Lab Fee Schedule S.4449 / HR 8188 Saving Access to Laboratory Services Act (SALSA)
Lobbyistsmr RUSSELL CONWELL RING · BRENNA MARIE LEAMER